Marc J.S. Wilson's Insider Trades & SAST Disclosures
Marc J.S. Wilson's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 473 Common Stock done at an average price of $15.0 . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marc J.S. Wilson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 31 Dec 2024 | 473 | 111,565 (0%) | 0% | 15.0 | 7,086 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 26 Sep 2024 | 25,000 | 89,000 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 26 Sep 2024 | 25,000 | 111,092 (0%) | 0% | 51.1 | 1,277,750 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 26 Sep 2024 | 25,000 | 136,092 (0%) | 0% | 15.3 | 382,250 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 25 Jul 2024 | 19,056 | 0 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 25 Jul 2024 | 19,056 | 130,148 (0%) | 0% | 9.3 | 176,840 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 25 Jul 2024 | 19,056 | 111,092 (0%) | 0% | 53.9 | 1,026,737 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 15 Jul 2024 | 25,000 | 136,092 (0%) | 0% | 20.0 | 500,500 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 15 Jul 2024 | 25,000 | 66,000 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 15 Jul 2024 | 25,000 | 111,092 (0%) | 0% | 55 | 1,375,000 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 28 Jun 2024 | 32,129 | 19,056 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 28 Jun 2024 | 32,129 | 143,221 (0%) | 0% | 9.3 | 298,157 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 28 Jun 2024 | 32,129 | 111,092 (0%) | 0% | 43.6 | 1,401,146 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 18 Mar 2024 | 6,942 | 110,630 (0%) | 0% | 42.9 | 297,881 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 18 Mar 2024 | 3,983 | 117,572 (0%) | 0% | 38.1 | 151,912 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 04 Mar 2024 | 95,500 | 95,500 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 04 Mar 2024 | 25,500 | 121,555 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharmaceuticals Inc | Wilson Marc J.S. | CFO | 02 Jan 2024 | 10,000 | 51,185 | - | - | Non-qualified stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Wilson Marc J.S. | CFO | 02 Jan 2024 | 10,000 | 96,055 (0%) | 0% | 35.5 | 354,700 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc Wilson J.S. | CFO | 02 Jan 2024 | 10,000 | 106,055 (0%) | 0% | 9.3 | 92,800 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 20 Jun 2023 | 20,000 | 115,158 (0%) | 0% | 9.3 | 185,600 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 20 Jun 2023 | 20,000 | 71,185 | - | - | Non-qualified stock option (Right to Buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 20 Jun 2023 | 20,000 | 95,158 (0%) | 0% | 20.0 | 399,400 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 20 Jun 2023 | 10,922 | 95,158 (0%) | 0% | 20.0 | 218,003 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 16 Mar 2023 | 1,666 | 106,080 (0%) | 0% | 17.1 | 28,522 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 01 Mar 2023 | 112,850 | 112,850 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 01 Mar 2023 | 24,200 | 107,746 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 31 Dec 2022 | 1,446 | 83,064 (0%) | 0% | 11.0 | 15,935 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 31 Dec 2022 | 482 | 83,546 (0%) | 0% | 11.0 | 5,312 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 28 Feb 2022 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO | 28 Feb 2022 | 19,500 | 81,618 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharmaceuticals Inc | Marc J.S. Wilson | CFO and Secretary | 26 Feb 2021 | 114,000 | 114,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges